Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q2 EPS of ($0.25), $0.21 worse than the analyst estimate of ($0.04).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.